Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
青松股份
300132
5
川寧生物
301301
(Q1)2025/03/31 | (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 14.65%1,234.8萬 | 30.53%5,129.2萬 | 35.71%1,534.2萬 | 27.23%1,337.3萬 | 24.28%1,180.7萬 | 34.98%1,077萬 | 74.89%3,929.5萬 | 57.54%1,130.5萬 | 69.92%1,051.1萬 | 88.83%950萬 |
營業收入 | 14.65%1,234.8萬 | 30.53%5,129.2萬 | 35.71%1,534.2萬 | 27.23%1,337.3萬 | 24.28%1,180.7萬 | 34.98%1,077萬 | 74.89%3,929.5萬 | 57.54%1,130.5萬 | 69.92%1,051.1萬 | 88.83%950萬 |
主營業務成本 | 26.07%203.6萬 | 33.22%833.4萬 | 49.48%257.1萬 | 32.94%224.8萬 | 25.25%190萬 | 21.61%161.5萬 | 25.15%625.6萬 | 13.98%172萬 | 26.19%169.1萬 | 26.31%151.7萬 |
毛利 | 12.64%1,031.2萬 | 30.02%4,295.8萬 | 33.24%1,277.1萬 | 26.13%1,112.5萬 | 24.10%990.7萬 | 37.65%915.5萬 | 89.12%3,303.9萬 | 69.14%958.5萬 | 82.01%882萬 | 108.43%798.3萬 |
營業費用 | -24.33%2,374.9萬 | 34.55%1.02億 | 19.74%2,304.5萬 | 31.55%2,413.6萬 | 21.00%2,388萬 | 66.84%3,138.7萬 | 26.91%7,614.2萬 | 12.25%1,924.6萬 | 22.55%1,834.8萬 | 32.95%1,973.5萬 |
銷售和管理費用 | -25.05%2,123.2萬 | 41.56%9,131.7萬 | 19.02%2,024萬 | 38.21%2,163.2萬 | 28.32%2,111.5萬 | 84.00%2,833萬 | 28.90%6,450.9萬 | 20.60%1,700.5萬 | 23.45%1,565.2萬 | 31.76%1,645.5萬 |
研發費用 | -17.66%251.7萬 | -4.32%1,113.1萬 | 25.17%280.5萬 | -7.12%250.4萬 | -15.70%276.5萬 | -10.51%305.7萬 | 16.89%1,163.3萬 | -26.43%224.1萬 | 17.58%269.6萬 | 39.28%328萬 |
營業利潤 | 39.56%-1,343.7萬 | -38.02%-5,949萬 | -6.35%-1,027.4萬 | -36.56%-1,301.1萬 | -18.90%-1,397.3萬 | -82.80%-2,223.2萬 | -1.35%-4,310.3萬 | 15.84%-966.1萬 | 5.91%-952.8萬 | -6.70%-1,175.2萬 |
淨非營業利息收入(費用) | -51.77%-145.7萬 | -144.41%-439.7萬 | -162.52%-152萬 | -91.98%-95.8萬 | -99.38%-95.9萬 | -300.00%-96萬 | -990.30%-179.9萬 | -250.91%-57.9萬 | -49.9萬 | -48.1萬 |
利息費用 | 51.77%145.7萬 | 144.41%439.7萬 | 162.52%152萬 | 91.98%95.8萬 | 99.38%95.9萬 | 300.00%96萬 | 990.30%179.9萬 | 250.91%57.9萬 | --49.9萬 | --48.1萬 |
其他淨收入(費用) | 7.57%112.3萬 | 3.30%397.7萬 | -3.94%107.2萬 | -13.16%91.7萬 | 53.25%94.4萬 | -1.69%104.4萬 | 180.41%385萬 | -1.76%111.6萬 | 221.95%105.6萬 | 1,911.76%61.6萬 |
其他非經營收入(費用) | 7.57%112.3萬 | 3.30%397.7萬 | -3.94%107.2萬 | -13.16%91.7萬 | 53.25%94.4萬 | -1.69%104.4萬 | 180.41%385萬 | -1.76%111.6萬 | 221.95%105.6萬 | 1,911.76%61.6萬 |
稅前利潤 | 37.82%-1,377.1萬 | -45.94%-5,991萬 | -17.51%-1,072.2萬 | -45.49%-1,305.2萬 | -20.41%-1,398.8萬 | -95.31%-2,214.8萬 | 0.65%-4,105.2萬 | 13.17%-912.4萬 | 8.44%-897.1萬 | -5.15%-1,161.7萬 |
所得稅 | -113.16%-5,000 | -62.59%5.5萬 | -282.05%-7.1萬 | 17.50%4.7萬 | 20.59%4.1萬 | 11.76%3.8萬 | 34.86%14.7萬 | 39.29%3.9萬 | 25.00%4萬 | 47.83%3.4萬 |
除稅後利潤 | 37.95%-1,376.6萬 | -45.55%-5,996.5萬 | -16.24%-1,065.1萬 | -45.37%-1,309.9萬 | -20.41%-1,402.9萬 | -95.06%-2,218.6萬 | 0.55%-4,119.9萬 | 13.03%-916.3萬 | 8.33%-901.1萬 | -5.24%-1,165.1萬 |
持續經營利潤 | 37.95%-1,376.6萬 | -45.55%-5,996.5萬 | -16.24%-1,065.1萬 | -45.37%-1,309.9萬 | -20.41%-1,402.9萬 | -95.06%-2,218.6萬 | 0.55%-4,119.9萬 | 13.03%-916.3萬 | 8.33%-901.1萬 | -5.24%-1,165.1萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 37.95%-1,376.6萬 | -45.55%-5,996.5萬 | -16.24%-1,065.1萬 | -45.37%-1,309.9萬 | -20.41%-1,402.9萬 | -95.06%-2,218.6萬 | 0.55%-4,119.9萬 | 13.03%-916.3萬 | 8.33%-901.1萬 | -5.24%-1,165.1萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | 37.95%-1,376.6萬 | -45.55%-5,996.5萬 | -16.24%-1,065.1萬 | -45.37%-1,309.9萬 | -20.41%-1,402.9萬 | -95.06%-2,218.6萬 | 0.55%-4,119.9萬 | 13.03%-916.3萬 | 8.33%-901.1萬 | -5.24%-1,165.1萬 |
基本每股收益 | 49.04%-0.53 | -33.17%-2.65 | 2.27%-0.43 | -32.56%-0.57 | -16.07%-0.65 | -89.09%-1.04 | 1.49%-1.99 | 13.73%-0.44 | 10.42%-0.43 | -3.70%-0.56 |
稀釋每股收益 | 49.04%-0.53 | -33.17%-2.65 | 2.27%-0.43 | -32.56%-0.57 | -16.07%-0.65 | -89.09%-1.04 | 1.49%-1.99 | 13.73%-0.44 | 10.42%-0.43 | -3.70%-0.56 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- |